When a company is in a Pre-IND phase and reports b
Post# of 36537
(Total Views: 252)
Posted On: 02/03/2021 9:41:22 AM
When a company is in a Pre-IND phase and reports back to the FDA the data, the FDA provides guidance on how to proceed. This is normal and a good thing in that the FDA wants a successful outcome and not have the early study protocol later questioned. I get your point though.
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼